1[2]van Halm VP,van Denderen JC,Peters MJ,et al.Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis[J].Ann Rheum Di,2006,65(11):1473-1477.
2[3]Divecha H,Sattar N,Rumley A,et al.Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects:relevance of systemic inflammation[J].Clin Sci (Lond),2005,109(2):171-176.
3[4]Mathies H.Diagnostic criteria in ankylosing spondylitis[J].Dtsch Med Wochenschr,1984,109(10):382-385.
6[7]Huffer LL,Furgerson JL.Aortic root dilatation with sinus of valsalva and coronary artery aneurysms associated with ankylosing spondylitis[J].Tex Heart Inst J,2006,33(1):70-73.
4He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004,110:405-411.
5Gardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [ NHANES Ⅲ ] ,1988-1994) . Am J Cardiol, 2000, 86:299-304.
6Rodriguez C, Pablos-Mendez A, Palmas W, et al. Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians ≥65years of age living in New York City . Am J Cardiol, 2002,89:178-183.
7Heim DL, Holcomb CA, Loughin TM. Exercise mitigates the association of abdominal obesity with high-density lipoprotein cholesterol in premenopausal women: results from the third National Health and Nutrition Examination Survey.J Am Diet Assoc,2000,100:1347-1353.
3Caliskan M,Erdogan D,Gullu H,et al.Impaired coronary mi- crovascularand left vcntricular diastolic functions in pa- tients with ankylosing spondylitis [J].Atherosclerosis, 2008,19(6) : 306-312.
4Bernner F,Kunz A,Weber U,et al.Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population[J].Clin Rheumatol,2006,25(1):24-29.
5Heslinga SC,Van Dongen CJ,Konings TC,et aLDiastolic left ventricular dysfunction in ankylosing spondylitis:a sys- tematic review and meta-analysis[J].Semin Arthritis Rheum, 2014,44(1 ): 14-19.
6Yildirir A, Aksoyek S, Calguneri M.Echocardiographic evi- dence of cardiac involvement in ankylosing spondylitis[J]. Clin Rheumatol, 2002,21(2) : 129-134.
8Bertram Pitt MD,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J].N Engl J Med, 1999,341( 10): 709-717.
9Pitt B,Remme W,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunc- tion after myocardial iufarction[J].N Engl J Med, 2003, 348(14) : 1309-1321.
10Toussirot E,Bahjaoui-Bouhaddi M,Poncet J,et al.Ab- normal autonomic cardiovascular control in ankylosing spondylitis[J].Ann Rheum Dis, 1999,58 (8) : 481-487.
